Biosense Webster, Inc.
Clinical trials sponsored by Biosense Webster, Inc., explained in plain language.
-
New heart catheter aims to tame stubborn AFib in major trial
Disease control Not yet recruitingThis study tests a new device called the VARIPULSE catheter system for people with persistent atrial fibrillation (a type of irregular heartbeat that lasts more than a week). The procedure uses heat energy to isolate certain veins in the heart to restore normal rhythm. About 920 …
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated May 26, 2026 06:22 UTC
-
New heart ablation system aims to simplify AFib treatment
Disease control Not yet recruitingThis study tests a new pulsed field ablation system (VARIPULSE catheter and TRUPULSE generator) with updated software in 50 adults with persistent atrial fibrillation (an irregular heart rhythm lasting over 7 days). The goal is to see how well the system works during the procedur…
Phase: NA • Sponsor: Biosense Webster, Inc. • Aim: Disease control
Last updated May 15, 2026 11:55 UTC